Test Price
2,800 AED✅ Home Collection Available
FKTN Gene NGS Test for Fukuyama Congenital Muscular Dystrophy in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين FKTN للكشف عن الحثل العضلي الخلقي فوكوياما في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
This test delivers precise, DHA‑approved Next Generation Sequencing of the entire FKTN gene, critical for definitive diagnosis of Fukuyama Congenital Muscular Dystrophy (FCMD) in infants and children. Clinical correlation is performed by DHA‑licensed neurologists, ensuring actionable results for families and physicians.
يقدم هذا التحليل تسلسلًا جينيًا دقيقًا لجين FKTN، بتقنية الجيل التالي (NGS) ومعتمد من هيئة الصحة بدبي، لتشخيص الحثل العضلي الخلقي فوكوياما (FCMD) لدى الرضع والأطفال، مع استشارة طبية متخصصة.
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited NGS processing with AI‑assisted variant interpretation (ClinGen/ACMG 2026).
- Premium Logistics: Paid hospital‑grade home collection through ISO-certified cold‑chain transport and VIP mobile phlebotomy (8 AM–11 PM).
- Clinical Guidance: Telephonic post‑test clinical guidance with a DHA‑licensed genetic counsellor for result interpretation and family planning.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731; government and major private insurances accepted.
Test Overview & Comparison
This NGS panel sequences the entire coding region of the FKTN gene to detect mutations causing Fukuyama Congenital Muscular Dystrophy (FCMD), a severe neuromuscular disorder. يقوم هذا الفحص بتسلسل كامل المنطقة المشفرة لجين FKTN للكشف عن الطفرات المسببة للحثل العضلي الخلقي فوكوياما. Ideal for confirmatory diagnosis, carrier screening, and family planning within the UAE’s advanced genetic testing framework.
| Feature | Our FKTN NGS Test | Closest Alternative (Sanger / Single‑Gene) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity; full gene coverage (coding exons & splice sites) | Limited to known hotspots; may miss novel or deep intronic variants |
| Methodology | Next Generation Sequencing (NGS) with Illumina platform; AI‑powered variant classification | Sanger sequencing of select exons; no copy‑number variation detection |
| Turnaround Time | 3–4 weeks from sample receipt | 4–6 weeks, often requiring multiple rounds |
Physician Insight & Safety Protocol
“Fukuyama congenital muscular dystrophy is a devastating paediatric condition that demands the earliest possible genetic confirmation. This NGS test, performed on a simple blood draw, gives families clarity,” says Dr. Prabhakar Reddy (DHA: 61713011).
“Always interpret results alongside clinical findings and imaging; a negative report does not exclude other congenital muscular dystrophies.”
“Genetic counselling is mandatory before testing to discuss implications for the child and the extended family.”
⚠ Medication Warning
Do not discontinue any prescribed medication, including anti‑epileptics or nutritional supplements, without consulting your treating physician. This test does not substitute for ongoing clinical management.
Exclusion Criteria & ER Red Flags
- Neonate in acute respiratory distress or haemodynamic instability – stabilise before sample collection.
- Active seizure requiring emergency intervention; coordinate testing after seizure control.
- If the child exhibits severe hypotonia with feeding failure and recurrent aspiration, urgent inpatient evaluation takes priority.
- ER Red Flags: sudden loss of motor milestones, new‑onset stridor, or desaturation episodes – seek immediate medical care.
Patient FAQ & Clinical Guidance
What is the FKTN NGS test and who should consider it?
The FKTN NGS test detects mutations in the FKTN gene causing Fukuyama congenital muscular dystrophy with 99.9% sensitivity, helping families confirm diagnosis. It is recommended for infants with hypotonia, delayed motor milestones, or brain MRI abnormalities typical of FCMD, as well as for carrier screening in at‑risk couples. يكتشف تحليل جين FKTN الطفرات المسببة للحثل العضلي الخلقي فوكوياما بدقة 99.9%، ويوصى به للرضع الذين يعانون من نقص التوتر أو تأخر الحركة أو تشوهات الدماغ.
How accurate is this NGS compared to traditional genetic testing?
Achieving 99.9% diagnostic sensitivity, this DHA‑accredited NGS assay covers every coding exon of FKTN, unlike older methods that miss novel or copy‑number variants. It reduces the need for multiple single‑gene tests and provides a comprehensive answer within 3–4 weeks. بدقة تشخيصية تبلغ 99.9%، يغطي هذا التحليل جميع الإكسونات المشفرة لجين FKTN، متجاوزًا الفحوصات التقليدية التي قد تفوت طفرات جديدة.
How long do results take and what does the home collection process involve?
Results are ready in 3–4 weeks; a DHA‑licensed phlebotomist brings hospital‑grade, cold‑chain collection equipment to your home between 8 AM and 11 PM, ensuring sample integrity. A genetic counselling session is required beforehand to document the family pedigree and provide informed consent. تظهر النتائج خلال 3 إلى 4 أسابيع؛ يصل أخصائي سحب الدم المرخص من هيئة الصحة بدبي إلى منزلك مع معدات حفظ مبردة، بعد جلسة استشارة وراثية لتوثيق التاريخ العائلي.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians